Detalhe da pesquisa
1.
Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease.
Mov Disord
; 38(1): 68-81, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36267007
2.
Accurate Detection of α-Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) Cohort.
Mov Disord
; 38(4): 567-578, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36781413
3.
Cerebrospinal α-Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal Cohort.
Mov Disord
; 36(9): 2048-2056, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33978256
4.
Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa).
Mov Disord
; 34(1): 67-77, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30468694
5.
The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
Mov Disord
; 33(1): 88-98, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28843021
6.
Dynamic interplay of cognitive functioning and depressive symptoms in patients with Parkinson's disease.
Neuropsychology
; 36(4): 266-278, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35175065
7.
Longitudinal Change and Progression Indicators Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale in Two Independent Cohorts with Early Parkinson's Disease.
J Parkinsons Dis
; 12(1): 437-452, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34719511
8.
Monitoring of 30 marker candidates in early Parkinson disease as progression markers.
Neurology
; 87(2): 168-77, 2016 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27164658
9.
Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort.
Neurology
; 81(14): 1226-34, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23997153